In vitro susceptibility of canine and feline Escherichia coli to fosfomycin

Veterinary Microbiology

Volumn 149, Issue 1-2, 2011, Pages 277-282

  Hubka, Patrick ^a   Boothe, Dawn M ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Escherichia coli; Fosfomycin; Minimum inhibitory concentration; Multi drug resistance; Urinary tract infection

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBENICILLIN; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; FOLIC ACID ANTAGONIST; FOSFOMYCIN; GENTAMICIN; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TICARCILLIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAT; CONTROLLED STUDY; DOG; EPSILOMETER TEST; ESCHERICHIA COLI; EXTREME DRUG RESISTANCE; FECES; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NO DRUG RESISTANCE; NONHUMAN; SINGLE DRUG RESISTANCE; UNITED STATES; URINARY TRACT;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CATS; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FLUOROQUINOLONES; FOSFOMYCIN; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; URINE;

CANIS FAMILIARIS; ESCHERICHIA COLI; FELIDAE;

EID: 79952102137     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.10.025     Document Type: Article

References (25)

1. Anonymous, 2007. Forrest Pharmaceuticals Inc. Monural Sachet Package® insert. Revised 7/07.
2. Barry A.L., Fuchs P.C. In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrob. Agents Chemother. 1991, 35(6):1235-1238.
3. Bergan T. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives. Chemotherapy 1990, 36:10-18.
4. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19 2008, CLSI, Wayne, PA, USA.
5. Clinical and Laboratory Standards Institute, 2008b. M31-A3 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, Approved Standard ed. 3. ISBN 1-56238-2008 659-X.
6. Clinical and Laboratory Standards Institute, 2008c. M37-A3 Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents, Approved Guideline, ed. 3, ISBN 1-56238-660-3.
7. Clinical and Laboratory Standards Institute, 2008d. Performance Standards for Antimicrobial Susceptibility Testing: Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters, Approved Guideline.
8. Cooke C.L., Singer R.S., Jang S.S., Hirsch D.C. Enroflxoacin resistance in Eschericia coli isolated from dogs with urinary tract infections. JAVMA 2002, 220:190-192.
9. Debavalya N., Boothe D.M., Hathcock T. Multi-drug resistance in fecal E. coli following routine enrofloxacin but not amoxicillin therapy in dogs. Annual American College of Veterinary Internal Medicine (ACVIM) Forum 2008.
10. DebRoy C., Maddox C.W. Identification of virulence attributes of gastrointestinal Escherichia coli isolates of veterinary significance. Anim. Health Res. Rev. 2001, 2:129-140.
11. Falagas M.E., Kanellopoulou M.D., Karageorgopoulos D.E., Dimopoulos G., Rafailidis P.I., Skarmoutsou N.D., Papafrangas E.A. Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:439-443.
12. Falagas M.E., Kastoris A.C., Kapaskelis A.M., Karageorgopoulos D.E. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 2010, 10(1 (January)):43-50.
13. Frossard M., Joukhadar C., Erovic B.M., Dittrich P., Mrass P.E., Van Houte M., Burgmann H., Georgopoulos A., Muller M. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob. Agents Chemother. 2000, 44(10):2728-2732.
14. Fuchs P.C., Barry A.L., Brown S.D. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods. J. Antimicrob. Chemother. 1999, 43:137-140.
15. Gray K.J., Gascoyne-Binzi D.M., Nicholson P., Heritage J., Hawkey P.M. Transmissible fosfomycin resistance markers in urinary isolates and imported foodstuffs in the UK during 1994 and 1995. J. Antimicrob. Chemother. 2001, 4:735-748.
16. Gutierrez O.L., Ocampo C.L., Aguilera J.R., Luna J., Sumano L.H. Pharmacokinetics of disodium-fosfomycin in mongrel dog. Res. Vet. Sci. 2008, 85:156-161.
17. Joukhadar C., Klein N., Dittrich P., Zeitlinger M., Geppert A., Skhirtladze K., Frossard M., Heinz G., Müller M. Target site penetration of fosfomycin in critically ill patients. J. Antimicrob. Chemother. 2003, 51(5):1247-1252.
18. Kahan F.M., Kahan J.S., Cassidy P.J., Kropp H. The mechanism of action of fosfomycin(phosphomycin). Ann. N.Y. Acad. Sci. 1974, 235:364-385.
19. Marchese A., Gualco L., Debbia E., Schito A., Gian C., Schito A.M. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int. J. Antimicrob. Agents 2003, 22:S53-S59.
20. Nilsson A., Berg I., Otto G., Aspevall O., Kahlmeter G., Andersson D.I. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob. Agents Chemother. 2003, 9(47):2850-2858.
21. Samonis G., Maraki S., Rafailidis P.I., Kapaskelis A., Kastoris A.C., Falagas M.E. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycinand other antimicrobials. Future Microbiol. 2010, 5(6):961-970.
22. Shaheen B.W., Boothe D.M., Oryarzabal O. The role of class 1 and 2 integrons in mediating antimicrobial resistance among canine and feline clinical E. coli isolates from the USA. Vet. Microbiol. 2010, 10.1016/j.vetmic.2010.01.018.
23. Shaheen, B.W., Boothe, D.M., Oyarzabal, O.A., Smaha, T., in press-a. Antimicrobial resistance profiles and clonal relatedness of canine and reline Escherichia coli pathogens expressing multidrug resistance in the United States. J. Vet. Intern. Med.
24. Shaheen, B.W., Boothe, D.M., Wang, C.M., in press-b. The contribution 1 of gyrA mutation and efflux to fluoroquinolone resistance and its association with multi-drug resistance in canine and feline pathogenic E. coli 3 isolates from USA. Am. J. Vet. Res.
25. Woodyer R.D., Zhao A., Thomas P.M., Kelleher N.L., Blodgett J.A.V., Metcalf W.W., van der Donk W.A., Huimin Z. Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. Chem. Biol. 2006, 13(11):1171-1182.